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MENGKAJI PRAKTTS PENJAGAAN FARMASI DARI PERSPEKTIF AHLI 
}'ARMASI Dl MALAYSIA 
ABSTRAK 
Objektif ka_jian ini adalah untuk meneroka dan mengumpul infonnasi dasar 
yang diperlukan untuk melaksanakan praktis penjagaan farmaseutikal (PC) di 
Malaysia. Kajian ini juga menilai kefahaman, persepsi, sikap dan penghalang 
terhadap konsep PC, dan pada masa yang sama untuk menunjukkan situasi praktis 
fannasi dalam konteks pelaksanaan PC. Ini aclalah suatu soal-selidik keratan rentas 
·" yang melibatkan ahli-ahli farmasi hospital dan komuniti eli Malaysia yang 
menggunakan penclekatan mengeposkan borang-borang soal-seliclik yang beserta 
setem. Dalam aspek kogniLiL lebih 70% dan 60% ahli fannasi hospital dan komuniti 
mempunyai kefahaman yang tepat mengenai proses PC rnanakala hanya 17% dan 
19%, masing-rnasingnya. gaga! bersetuju clengan penyataan yang tepat. Situasi 
praktis sernasa menunjukkan, kebanyakkan responclen eli hospital clan kornuniti 
melakukan akti viti-aktiviti praktis farmasi, tambahan pula, mereka juga kompeten 
untuk menjalankan aktiviti-aktiviti tersebut dan mengakui kepentingan aktiviti ini. 
Namun, data menunjukkan tidak ramai ahli fannasi komuniti (32%) rnenjalankan 
aktiviti penc!ispensan, hanya 34% mengaku kompeten dan 43% daripac!a mereka 
bersetuju tentang kepentingan aktiviti tersebut. Berkaitan de~1gan taburan masa 
dalam praktis 1~1rmasi menun_jukkan balwwa kedua-dua responclens claripada farmasi 
hospital dan komuniti rnemerlukan perunlukkan nws<J yang lebill clalam 
melaksanakan aktiviti-aktiviti penjagaan pesakit. Tambahan lagi, responden daripacla 
komuniti memerlukan masa yang lebih untuk r11c!akukan aktiviti mendispens. Secara 
keseluruhannya, responden-n:spolldt:n clnri f'::11111asi hospital dan komuniti 
menunjukkan persepsi dan sikap positif mengenai kepentingan dan praktikaliti clalam 
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kesclurulwnnyn. JTSpunclen-rcspondcn dari fitrtmsi ital dan kmnuniti 
. . . . I - I ·1 ·r 1· . d l :itl :Jt<.::I,'.Cil~ll 'l'Jh'!ilJ:tguncanpradtGlliJ .aam 
r-Lu 1: un ~lcmikian, data 
memH1jukkan bahawa kurang d~ti·ip~tcl<i 5lY'c r-:.:.->[!u;,_:,·:J :-:·::pondcn hospital dan 
i lcilcitlgan-halangan yang 
rnernbantut pelaksamtdll !< · 1U1 lJ\.·I·k~iJl:L, ,_i .,,,_,"1 :::um:ana praktis seperti 
keLurangan masa dan tiad~t ~')tris pc:ndulltl )-C!lic'- 11i.i ·'- · praktis PC. Untuk 
ll1CfiCiltUkan variabJe-variabel I(:Sj)c)l:<k:l: \:lii:c_ ci :j> ,\ :fJcJ·;unaJkan i.rnplernentetsi 
') 
pral<..tis PC', nilai R- darip~1c! . . l!)'ct :tl!i!iJ.•;];; .·:-;: tel un1s yang cii l.akukan secar?,.. 
berasingan telah eli hi tung scbugCti 0.(J2. O.(J 1. d<lll \J.-1"1 l!t\ll!k persepsi-persepsi 
responden berkaitan dengan kepentingan. 1-d)lllpck'iJ';i ,;rin prukrikaliti, untuk 
membangun praklis SCllmU:!Jn:, i:u ii.·;Ivt;:u,l;l illi ill•..'lH!ii_ii.lkkan bahawa responde.n-
beberapa kt~rnusykilan tertcntu berkaitan dengan praktik:,ii;i a. Justen.! itu, kajian 
ini met:J 
ahli farrnasi . ' ! ill pl \..'l i !~..'J.J l~;:-11 
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AN li~XPLORATIVE STUDY ON PUA.H.JVIACEUTlCAL CARE PRACTICE 
FROM TliE PERSPECTfVE OF PIIARMACJSTS IN MALAYSIA. 
ABS'J'RAC'I' 
The objectives of this research \vere to explore and gather baseline 
information that is necessary for the implementation of pharmaceutical care (PC) 
practice in Malaysia. It went further to evaluate the understanding, perceptions, 
attitudes, and barriers towards the concept of PC as vvell as to describe the current 
pharmacy practice situation hom the context of PC implementation. This is a cross-
sectional survey of hospital and community pharmacists in Malaysia, employing th€' 
self-administered mailed questionnaire approach. In the cognitive aspects, over 70% 
and 60% of the hospital and community pharmacy respondents respectively, had a 
correct understanding of the PC process with only 17% <:md J 9% respectively, failing 
to agree with correct statements. The current practice situation revealed that, most 
hospital and community pharmacy respondents performing lhe pharmacy practice 
activities; in addition, they were competent to carry out lhese activities and perceived 
its importance. However, the data collected revealed 32% of the community 
pharmacy respondents performing the dispensing activities consequently, 34% of 
them were competent to practice the dispensing activities and 43% of them agreed 
about its importance. Regarding the distribution of time of the pharmacy practice 
revealed that both the hospital and community pharmacy respondents would like to 
spend more time in performiug the p8lient care activities. In addition, the community 
pharmacy respondent had the intention to spend more time engaging in dispensing 
activities. In general, hospital and community pharmacy respondents perceived 
importance and practicality of developing PC practice and skills to practice it In 
spite of this, the data revealed less than 50% of the hospital and community 
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pham1acy respondents were co1npetent lo deliver the PC practice. The barriers 
impeding the provision of PC seem to be related to practice settings such as 
insufficient time and no standard guideline for PC practice. [n order to determine the 
respondent's variables which could be the predictor for the implementation of PC 
practice, H..Z values of three separate linear regression analysis were computed as 
0.62, 0.61, and 0.42 for the respondent's perception of the importance, their 
competence, and the perceived practicality to develop and implement such practices 
in the local pharmacy settings. These findings indicated that the respondents had the 
intention to render pharmaceutical care but, they had certain doubt about the 
·" 
practicality of such practices. Thus, the study provides an insight into the 
pharmacists' thoughts and concerns regarding the implementation of PC practice in 
Malaysia. 
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CHAf'TEH 1 
1.1 Introdudion 
Over the past few decades, with the health care environment worldwide 
especially in the United States witnessing the gradual and remarkable growth of the 
·" managed care system and pharmacy practice becoming more medically 
sophisticated, pharmacists are employing innovative patient care strategies such as 
pharmaceutical care practice. The philosophy of pharmaceutical care has been 
accepted worldwide as the primary mission of pharmacy. Pharmaceutical care 
mandates that practitioners not only to dispense medications, but also to assume 
responsibility for improving the quality of patients' outcomes (Helper and Strand, 
1990). The traditional role of the pharmacist that involves in the preparation, 
dispensing and selling of medications is no longer adequate for the pharmacy 
profession to survive. Additionally, it has been argued that pharmacists have 
assumed a paternalistic role in discussions with patients about therapeutic options. 
Under this "pharmaceutical care" model, the patient delegates decision-making 
authority to the pharmacist. Implicit assumptions in delegating this authority include 
the perception that the "pharmacist knows best" and would be in the best position to 
make a therapeutic decision in the patient's best medical interests for the purpose of 
achieving definite results that illlprove " patient's quality of life (QoC) (Hepler and 
Strand, 1990). To achieve these results, plwrmncists need to co-operate with patients 
and other healthcare providers in designing, implementing, and rnonitoring a care 
plan aimed at preventing and resolving drug therapy problems (DTPs) (Bell et a!, 
2006; Haugb0lle and Sv)renscrL 2006: Blix et of., 2006; Soendergaard, 2006; 
Sturgess eta!., 2003). 
For the pharmaceutical care to achieve its goals it needs the traditional 
pharmacy to evolve and transform (Winslade, 1994; Winslade, 1993; Duncan-
Hewitt, 1992). The perception atld understanding towards pharmacy need to be 
changed, evolved, and transformed as well as to reorient the practising pharmacists 
to meet the challenges of the co11tempornry health care system. This is vital as the 
pharmacists are the main clri ve and ma!ll factor behind this transformation and 
application of pharmaceutical care practices. Hence, pharmacists' knowledge, 
perception, and attitude about the new emerging philosophy of pharmaceutical care 
are important. 
1.2 A historical perspective of pharmacy practice 
The practice of phatT1Jacy, in a historical sense. has evolved from a state of 
none or rninirnal pat.ient contact to a level where the pharmacists provide an 
individual patient-oriented service as depicted in (Figure 1.1 ). Pharmacy practice has 
been aptly described as evolving in three distinct stages. These stages are namely; (1) 
the traditional or drug distribution stage; before 1960s, generally, pharmacists are 
known as apothecaries, their function was to procure, prepare, and compound 
medicinal products. However, this role was gradually waned and taken over by the 
pharmaceutical industry. (2) the transitional or clinical pharmacy stage; born in the 
mid-1960s, The notion of the pharmacy practice had shifted to place much less 
emphasis on compounding and considerably more emphasis on clinical service 
delivery (Higby, 2003). (3) The patient-focused or pharmaceutical care stage (Hepler 
and Strand, 1990; Hepler, 1987) began in 1990 and continues to the present time. It 
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·" 
is the "patient care" era tli 1vhicl1 the plwrnwccutical care reached maturation and 
became the mainstream function of pharmacists. Patients and their effective 
treatment with drugs are now central to Lhc pharmacists' role. The pharmacist's role 
as a "therapeutic advisor" subsequently began to emerge. 
patient contact 
physician contact 
> patient contact or nlli'lirna1 
no patient contact 
/ 
c·unkal 
phannac:,· 
Indi,,·idual patient-
oriented service 
·" 
Disease-orien~.:ed 
Pro duc-c- oriented 
serv1ce 
L--------------------------------------------------------------~----
Figure 1.1: Evolution/ transformation of pharmacy practice 
1.3 The clinical pharmacy era 
The clinical pharmacy era. represents a period of rapid ex pans ion of l:l.mctions, 
professional transition, and developrnent of clinically oriented pharmacy. This eta is 
best characterized as a transitional period between the years of count-and-pour 
practice and the current era of pharmaceutical care. The notion of the pharmacy 
practice had shifted to place much less emphasis on compounding and considerably 
more emphasis on clinical s~Tvice clelivery (Vnluk alld !'lni1·, 2003). Conceptually, 
clinical pharmacy is drug use controlled in which Donald i3mclie (1967) expounded 
and stated his theory: 
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The ultimate goal of the service oj'phunmrcy must he the saj'e use oj' drugs by the 
public. In this context. the !noinsiremnjimclion ojp/wrnJucv is cliniccr! in nature, one 
that rnay be identfjied accurately as drug-use-control. 
By "drug-use-control" Brodie meant the sum total of knowledge, 
understanding, judgments, procedures, skills, controls and ethics that assures optimal 
safety in the distribution and use of medications (Brodie and Benson, 1976). The 
overall goal of clinical pharmacy activities is to promote the correct and appropriate 
use of medicinal products and devices (Table 1.1 ). 
The growth of clinical pharmacy in hospital has lead some people tQ,. 
incorrectly conclude; that clinical pbmmacy is a variety of hospital practice and or 
limited to hospital only (Hassan, 1993). Comrnunity pharmacy shift to clinical 
practice coincided with hospital pharmacy transforrnation. Unlike hospital pharmacy, 
the burdens of business nature like of the practice and the distance from the clinical 
environment made the transition slower and more diHicult (Higby, 2003; Posey, 
1997; Carter and Barnette, 1996; Sisson and Israel, 1996). 
In the local scene, transition occurred in the 1980s; in a large part because 
pharmacy educators, who initially lagged behind practitioners as advocates of 
clinical practice, saw the prospects for the future. Clinical pharmacy restored 
meaning to their teaching. Rather than just supporting ths::ir own scientific 
disciplines. The pharmacy authorities have given a lot of emphasis on clinical 
pharmacy. In a continuing effort to advance, expand, and promote the practice of 
clinical pharmacy in Malaysia, the School of Pharmaceutical Sciences, (USM) began 
adapting its curriculum to focus on the patient and on clinical practice. Many of these 
changes had been brought about by new faculty members returning from the United 
States with Pharm.D degrees beginning in 1983. Curriculum changes were made 
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thereafter; the proportion of clinical components increased (Ab Rahman and Bahari, 
2004). The concept of clinical pharmacy practice in hospital settings comprises 
functions require pharmacists applying their scientific body of knovvledge to improve 
and promote health by ensuring safety and efficacy of drug use and drug use- related 
therapy in seven major categories: prescribing drugs, dispensing and administrating 
drugs, documenting professionnl activities. direct patient involvement, reviewing 
drug use, education, and consult::Jlion U-lassan, 1993). Community pharmacy practice 
in Malaysia varies from one pharmacy to another. Chain-store pharmacies usually 
offer a significant proportion of non-professional services and activities alongside the 
... 
traditional professional services. Srnallcr independent pharrnacies normally focus on 
professional pharmacy services. Both types are representative of community 
pharmacy practice in Malaysia (Wong, 200 l). In general, the application of clinical 
knowledge and skills although necessary, are not sufi~cient for effective 
pharmaceutical care (Todd er of., 1987). There must also be an appropriate 
philosophy of practice called pharmaceutical care and an appropriate organizational 
structure to facilitate providing that care called pharmaceutical care system (Hepler 
and Strand, 1990). 
Table 1.1: The overall goal of clinical phnnnacy* 
--------
Clinical pharnwcy :;ctiviiics Gw,il 
---·----·----~~----------·--·-- -
Using the most effective treatme11t for each Maximizing the clinical eflect of medicines 
type of patient 
Monitoring the therapy course and paticnt~s Minimizing the risk of treatment-induced 
compliance with ther<1py adverse events 
----------··---~--
Trying to provide the best treatment Minimizing the expenditures for 
alternative for the greatest nurnber of pharmacological treatments born by the NHS 
patients and by patients 
*Source: Alminana et al., (2007) 
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1.4 The pharmaceutical care 
1.4.1 The definitions and the concept of phnnnaccutical rart~ practice 
Since the landmark description of the concept of pharmaceutical care by 
Hepler and Strand (1990), there have been numerous definitions of the concept 
(Hepler, 1993) and suggestions and also evaluations of models for implementing 
pharmaceutical care practice. These include the Therapeutic Outcome Monitoring 
(TOM) model of Grainger-Rousseau et ul., ( 1997); and the Pharmacists 
Implementation of Pharmaceutical Care (PIPC) model of Odedina et a!., (1997) 
among others. Currently, pharmaceutical care is widely understood as "the direct, 
·" 
responsible provision of medication-related care to achieve definite outcomes 
intended to improve the patient's quality of life". ·rhe principsl elements of 
pharmaceutical care are that it is medication relalccL iL is care that is directly 
provided to the patient by pharmacist in collaboration with the patients and 
healthcare professionals. This role requires pharmacists to apply a higher level of 
drug knowledge, clinical skill, and independent judgment to their work which 
involves designing, implementing and monitoring a therapeUlic plan. The care 
provided is to produce definite outcomes; these outcomes are intended to improve 
the patient's quality of life; ami the plwn11acisls who practice PC have accepted 
personal responsibility for their patients' oulcurnes. These LhenlJ~eutic outcomes are: 
cure of a disease, elirninalion or rec!tlctiull uf a patient's symptoms, arresting or 
slowing a disease process or syn1ptorns. outcomes is the goal of pharmaceutical care. 
Pharmaceutical care invol vcs identifying, rcsol ving, and preventing drug-related 
problems (Strand eta!., 199J; ASHP., J 993). A drug-related probkn1 was defined as 
"an event or circumstance involving medication therapy that actually or potentially 
interferes with an optimum outcome for specific patient. Drug-related problems have 
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been categorized as follows: untreated indication, improper drug selection, sub-
therapeutic dosage, over-dosage, ad verse drug reaction, drug interaction, failure to 
receive drug, and drug usc without indication (Strand e1 ul .. \ 99J: ASHP, 1993). 
The experience of pharmacists seeking to incorporate this philosophy into 
everyday practice have led Strand and her colleagues in (1997) to redefined 
pharmacet1tical care, it is considered more prugmatic detinition, as "a practice for 
which the practitioner takes responsibility for patient drug therapy needs and is held 
accountable for this commitment. This later clctinition bus three components which 
comprise of: (1) a philosophy of practice, (2) a consistent and systematic patient care 
process, and (3) a practice management system. Most major pharmacy organizations 
in developed countries (e.g., the American 11 lwrmaceutical ;\ssociation [APhA] and 
the American Society of Health-System Pharmacists [i\SHP]) have since adopted the 
pharmaceutical care philosophy. 
World }-Iealth Organization (WHO), (1998) ddinecl pharmaceutical care as a 
patient care system that continually observes the short-term results of the therapy in 
progress and helps to make corrections to improve management outcomes. The term 
requires multidisciplinary approach and the term would normally consist of a patient, 
a pharmacist, and a general practitioner. 
1.4,2 The significance of the pharmaceutical care 
The concept of pharmaceutical care evolved to help rnaxnmze the 
contributions of pharmacists in reducing and combating the drug-related morbidity 
and mortality to improve outcomes and decrease health care costs, since drug-related 
morbidity and mortality is costly both hom human resource and a financial 
perspective. Research demonstrated that; where pharmaceutical care services are 
applied, they contribute significant benefits to sociaL hurnanistic and economic 
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groupmgs (Ernst et al., 2003; Manasse and Thompson, 2003:. Ernst and Grizzle, 
2001; Classen et al., 1997; Johnson and Bootman, 1995). Pharmacists significantly 
can help satisfy drug related needs, optimize patient outcomes through 
pharmaceutical care services by identifying, detecting, resolving, and most 
importantly, preventing drug-related problems (Strand et aL 1990). 
A drug-related problem was defined as "an event or circumstance involving 
medication therapy that actually or potentially interferes with an optimum outcome 
for specific patient. Drug-related problems have been categorized as follows: 
untreated indication, improper drug selection, sub-therapeutic dosage, over-dosage, 
adverse drug reaction, drug interaction, failure to receive drug, and drug use without ·" 
indication (Strande/ a!., 1993; ASHP, 1993). 
Drug-related problems that are not identitlecl, detected. resolved. or prevented 
may result in drug-related morbidity and mortality. A drug-related morbidity can 
manifest as a treatment failure or as a new medical problem. Some cases of drug-
related morbidity, if unattended, can resull in drug-related mortality (Planas et al., 
2005). 
Studies conducted over the past decades indicated that drug related problems 
are widesprcnd and cause significant injury and death. Bates and colleagues (199 5) 
found that almost 2% of hospital admissions experienced a preventable adverse drug 
event. This resulted in an average increase in length of stay of 4.6 days and a $4700 
increase in hospital costs per admission. 
A lanclnwrk study by .fuimson nne! !Sootman, (1995) used a 
pharmacoeconomic model to identify that, in the USA the expenditure on treating 
drug-related morbidity and mortality is the same as the e:"pencliture on the medicines 
themselves, and this was the second most costly disease after cardiovascular disease. 
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They prophesied that 25 -SO<Yt) of the drug-related morbidity and mortality might be 
prevented through improved medicines management. In a 1997 follow-up study 
published in the American Joumal of Health-System Pharmacy, Johnson and 
Bootman noted thnt pharmacist intervention could reduce drug-related morbidity and 
mortality and could reduced health care costs. In 2001, Ernst and Grizzle updated 
Johnson and Hootman's cost-of-illness model to estimate that drug-related morbidity 
and mortality cost over$ 177 billion in t!Je year 2000. 
More recent studies eslinwte 58.9% (range, 32% to 86%) of drug-related 
hospital admissions are preventable (Winterstein et a!., 2002). Causes of preventable ,. 
drug-related hospital adrnissions have included adverse drug reaction, over-dosage 
and under-dosage, lack of a necessary drug therapy, patient non-adherence, 
inadequate follow-up, and problem with nonprescription drug (Fieelon et al., 2007; 
Pit et al., 2007; NANs, 2006; Sorensen eta!., 2005; Gurwirtz el ol., 2000; Dminell et 
al., 1996; Schneitman-Mclntire eta!., 1996; Lindley eta!., 1992; Bero et al., 1991). 
In the context of Malaysia, the drug related problems have received much 
attention during the past years. Through this period; several studies had been 
conducted, using many variables to investigate the existence of different categories 
of drug-related problems for different disease conditions in different practice 
settings. One study conducted by San-itT et a!., (1992) in ou.tpatient pharmacy 
demonstrated that a significant proportion of patients unable to tmclerstand 
prescription instructions, and only 21% of patients were able to comprehend 
complete antibiotics instructions. T'he problem of poor patient adherence has been 
extensively researched over the years (f\ziz et ol., 1999; Othman, 1991: Hassan el 
al., 1990b; Hassan et a!., l990c; Hassan e/ ol., 1989). Other study detected an 
alarmingly high prevalence of drug related problems on rnedication prescribed to 
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outpatients with type II diabetes (NIDDM) and hypertension. Since out of 392 
prescriptions, DRPs were detected in 272 (69%) of anti-diabetics and 319 (81%) of 
antihypertensive prescribed (Sararaks, 2005). The problems of adverse drug reaction 
reporting have been given more importance lately. Another study was conducted in 
Malaysia to determine the heq uency and types of drug administration errors in a 
hospital ward found that a total of 1118 administrations were observed in 66 
inpatients with 135 drug administration errors recorded. This means 12.1 errors per 
100 drug administrations. The most common types of drug administration errors 
were incorrect time (25.2%). foliO\vecl by incorrect technique of administration 
... 
(16.3% ). Others included incorrect drug preparation, incorrect dose and omission 
errors (1 0.4% each) (Chua et ol., 2005: Chua et ol., 2003) 
The problem of drug related therapy is a vvell- recognized problem in the local 
literature. Therefore, provision of pharmaceutical care in the local setting should 
target local problems and the outcomes of this service should be investigated, so that 
the significance or phannacL'utical care at the local level can be appreciated. 
1.5 Issues in implementing pharnHu.:etdical care 
The concept of phannaceutical care is capturing the attention of a growing 
number of practitioners. There are urgent needs to clarify a number of issues that 
shape and direct the implementation of pharmaceutical care. 
1.5.1 Onderstanding, knowledge, and awareness of pharmaceutical care practice 
Pharmaceutical care is the crucial philosophy ancl mi:;sion of pharmacy 
practice. Understanding and knowledge of this philosophy musl precede efforts to 
implement pharmaceutical care, which merits the highest priority in all practice 
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settings. Studies on pl1armacists- knowledge atJd unclerstancling of pharmaceutical 
care are scarce and not consistent in their findings 
Dunlop and Shaw (2002) established New Zealand community pharmacists' 
level of understanding of the plwrnwccutical care process. 'The study involved 377 
respondents who were younger and older, proprietors and employees pharmacists. 
Over 60% of the pharmacists had a correct understanding of pharmaceutical care. 
Study by Van Mil (1999), used the results of International Phannaceutical 
Federation (FIP) questionnaire. One of the questions specifically asked for the 
definition of pharmaceutical care used internationally. Six out of 30 responding 
·" 
countries indicated in that they used Hepler and Strand definition as their current 
working definition, 12 countries gave their own description or definition, which in all 
cases significantly different from Hepler and Strand definition. Twelve countries did 
not give a definition of pharmaceutical care. 
One study has described the current practice of hospital pharmacists in Kuwait 
revealed that, the lack of uniformity in the responses regarding the focus and 
objectives of pharmaceutical care indicates a lack of appropriate understanding in 
this matter. All respondents have shown willingness towards the 
implementation of pharmaceutical care services in their practice (A wad, 2006). 
Yet, very little is known about pharmacists' knowledge on pharmaceutical 
care in this country. One study in Malaysia involved 282 pharrnacists practicing at 
the outpatient pharmacy of 13 s!alc lwspitals, 67 clistricL hospitals, and 7-health clinic 
in West Malaysia revealed that, knowledge about pharmaceutical care in general is 
unsatisfactory. Although pharmaceutical care is rcgurckcl as. highly important, only 
5% of the pharmacists \Vcre considered to have adequate knowledge on 
pharmaceutical care (Othman, 2004). 
l J 
1.5.2 Competence and skills needed fo•· pharmaceutical care 
In essence pharmaceutical care is that component of pharmacy practice that 
can be performed by no one other than a competent pharmacist. Competence 
comprises adequate knowledge and skill to perform a particular function, and an 
attitude of commitment to the patient's valued interests (1\vleyer, 2003). In that 
context, the future direction of the pharmacist in hospital and community will 
continue to evolve towards patient-directed services that apply scientific knowledge 
and clinical skills Lo the prevention nne! resolution of clrug-reiatccl problems. 
Subsequently, the pharmaceutical care literature has demol\stratecl numcrou~ .. 
references to the expanding the role of "expert'' pharmacists for different disease 
conditions in a variety ofphannacy settings. As an example, in one thyroid clinic, a 
pharmacist can initiate, maintain or modify the dl'ug therapy of a selected group of 
patients under the guidelines of approved protocols. In this clinic, patients treated by 
the pharmacist include those receiving thyroid - suppression therapy, anti-thyroid 
drugs for Graves' disease or thyroid hormone supplementation after surgery or after 
radioactive iodine therapy. The pharmacist assesses patients, prescribes medications, 
orders laboratory tests, charts visits and therapeutic plans and educates patients about 
their conditions. Physicians may refer those noncompliant patients or those desiring 
additional information also are referred to the pharmacist.. Joint therapeutic 
management between the pharmacist and endocrinologist is necessary when there are 
major changes in thyroid status (Dong, 1990). 
Another pharmaceutical care program called a practice enhancement program 
(PEP) was designed by Farris et al., ( 1999) as part of the pharmaceutical care 
research and education project to help pharmacists acquire the necessary 
competencies, including skills. knowledge, and attitude to provide a comprehensive 
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pharmaceutical care to elderly ambulatory patients. The tools and processes used in 
the project increased community pharmacists' competency for providing 
pharmaceutical care. 
Thus, it is anticipated that the pharmaceutical literature will continue to 
provide evidence references to identify the umque contribution that competent 
pharmacist can make to disease management for patients with certain specific ru1d 
chronic conditions. for example several studies have been conducted to evaluate the 
ef:fecti veness of PC with regard to clinical, humanistic, and economic outcomes in 
patients with asthma (Hounkpati et a!., 2007; Mangiapane et ul., 2005; Gonzalez-
·" 
Martin eta!., 2002: Kheir eta!., 2001; Shaw eta!., 2000). Plwnnaceutical care sets 
out to maximize the benefits and minimize the risk of medicines and improve health 
by working in collaboration with diabetes patient and other healtll care providers 
(Motello et aL, 2006: Clifford et a!., 2005; Odegard eta!., 2005; Armor and Britton, 
2004; Sarkisian el a!., 2003; Cranor and Christensen, 2003; Crant et al., 2003; 
Nowak et al., 2002; Renders eta!., 2001; Jaber eta!., 1996). Numerous studies were 
conducted to evaltwte the pharmacists capacity to positively intluence the results of 
antihypertensive drug therapy tlll·(llt~,ll pharlllaceutical care (iVlatowe el al., 2008; De 
Castro et al., 2006; Chabot, 2003; Carter and Zillich, 2003; Garcao and Cabrita, 
2002; McAnaw et a!., 2001; Sen and Thomas, 2000; Paul el a!., 1998; Dong et al., 
1997; Lip and Beevers, 1997; Erickson et ul .. 1997). A study by Okamoto m1d 
Nakahiro, (2001) measured clinicaL econnruic, ami IHlJJWnistic outcornes associated 
with a phannacists-managed hypertension clinic compared with physician-tnru1aged 
clinics. The results fclund that pharmacists can be a cost-effective alternative to 
physicians in rnanagernent of patit.:'Ills, and they can improve clinical outcomes and 
patient satisfaction. Pharmaceutical care positively affects lipid values, quality of 
13 
life, and patient satislilction through provision of comprebcnsi ve pharmaceutical care 
(Pauos eta!., 2005; 'Tsuyki et of .. 2002; Nola cl a/., 2000~ Shibley and Pugh, 1997). 
A number of studies have proved the benefit of comperent pharmacists 
providing pharmaceutical care in psychiatry area (Bryce et u!., 2004; Jenkins and 
Bond, 1996). Other stndies aim to imestigate tile impact of a pharmacist-lead 
pharmaceutical cme program, involving optimization of drug treatment and intensive 
education and self-monitoring of patients with heart failure (Sadik et al., 2005; 
McMurray. 1999; Gattis et ol., 1999). Li and Kencller, (2004) reported· that 
community pharmacists managed postmenopausal osteoporosis through 
·" 
comprehensive pharmaceutical care. One study revealed the impact of a 
pharmaceutical care specialist I-IIV service provided by pharmacists to sample of 
patient with HIV infections (Gilbert, 2005; Bramble et al., 1999). ln a similar 
context, the profession of pharmacy has a unique opportunity to contribute 
effectively to gerontological care especially during the past 40 years whereby the 
elderly population has increase clrmnalically (Lyra Jr et a!., 2007; Grymonpre et al., 
2001; Beyth and Shorr, 1999; Stein, 1994 ). Several studies revealed pharntacists 
ability to positively affect drug-use management and contribution provides care to 
pediatric patients (Stergachis et u!., 2003: Uolh<1 cl of .. J ')92). 
In Malaysian context, the competent pharmacist's taking n .more active role in 
patient care is a well- recognized in the local literature. Stucly analyzed clinical 
pharmacists' interventions in the ICU of the Penang Clcnerul Lfospital (Penang, 
Malaysia) and nsscsscd tl1c pharmaco-econornic imJXICl ol' these interventions. In this 
study Pharmacists recommendations and interventions in tl1e JCU of a Malaysian 
hospital resulted in significant cost savings in terms ol· drug expenses (Zaidi et al., 
2003). Other study conducted ill Pcmtil[! ClcntraJ Hospital to evaluate the medication 
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compliance and the impact of pharmacist intervention in patients with congestive 
heart failure. More than 50% of the pharmacists' interventions and recommendations 
Yvere accepted in this study (i\kli;di t-:i of. :.2002). Severa] studies cleall with the 
pharmacists' ability to influence outcomes u[· diabetes mellitus therapy (~/laLhialagan 
et al, 2007, Khalid et al., 2007; Hoe el ol., 2004). Other studies were conducted to 
evaluate the pharmacists' capacity to positively inJ1ucnce the r~:suHs to quit smoking 
in Malaysian (Babar et ol .. 2007:. rvlagzuub. 2005; Mokttnl~d. 2004; Mohamed, 
2003). 
1.5.3 Perception, belt:•vior, and }:ttilude aboui the pharnutteut~.cal care ·" 
A positive pharmacist pcrccpliotL behavior. and attitude are pivotal towards 
the implementation of pharmaceutical care. A key aspect towards improving or 
preventing the occurrence or· drug related problems is changing the attitude, 
behavior, and perception of pharmacists as health cme professionals to know their 
physical and mentalllmitation, and to behave in a professiollal and courteous manner 
whilst at work. 
The concern about hurnan behaviors. which spurred the formulation of the 
Transtheoretical Model (TTM) of Change to explain, predict, and change multiple 
human behaviors in the 1970s and 1980s, (Prochaska and DiClemente, 1984 ), incited 
Berger and Grimley, in the 1990s, to apply the TTM to measure pharmacists' 
readiness for rendering pharmaceutical care. It also identified and measured factors 
that facilitate rendering pharmaceutical care and factors that are barriers, as well as 
the strength of these factors for each stage of readiness. The Tronstheoretical Model, 
which suggests that five stages of voluntary behavior change exist fi·om 
precontemplation, contemplation, preparation, action, and maintenance. Their 
findings support the theory behind the TTM: that IS. with any behavior change, 
1.'1 
individuals vvill tall into scvcrztl swges of rcadi ness for chanl~c, and the vast majority 
~- - ' ~ 
will not be ready to take action within the next six months. Also consistent with the 
theory, the cons of engaging in a behavior tended to be more salient for individuals 
m the pre-contemplation/contemplation stages than for those m the 
action/maintenance stages (Berger and Grimley, 1 997). 
An attitude can be defined as a learned disposition to respond in a particular 
manner to a given object (Campagna nne! Nevvlin, 1997). The important int1uence ol· 
attitudes on the practice behavior of plwrmacists has been noted and discussed in the 
literature (Fjortoft and Lee, 1994; Hansen and Ranelli, 1994; Lee and Fjortoft, 1993; 
·" 
Kirking, 1984; Baker, 1979; Knapp. 1979). These studies suggest that a pharmacist's 
choice to perform at a pril'ticular level of clrut]. therapy decision-maki.ng (DTDM) may 
be influenced by her or his attitude towards the ruk of pharmacy in the health care 
process towards the perceived appropriateness of specific action, tovvarcls her or his 
ability to effectively pcrforrn in a particular role, and towards a number of other 
lSSUCS. 
Several approaches to examwe pharmacists' intentions and behaviors in 
implementing phannrrceutical care have been pursued. A Pharmacists' 
Implementation ofPhannac~:uLiciJt Ca1·c (PJPC) model was developed by Odedina et 
al., (1996) from 617 community pharmacists i11 !·lorida (USA), These PIPC model 
included factors (attitude, perceivc~d behavioral controL social norm, intention, 
psychological appwisal proc<.::sses and pas! behavior recency). The PTPC model 
incorporates these variables or !~ictors which proposed by 'Theory of H ..easoned 
Action (Fishbein and Ajzen, 1975)" Planned Behavior (i-\jzen, 1985), Theory of 
T:!:ying (Bagozzi and Warsha\v, 1990), and Theory of Goal Directed Behavior 
(Bagozzi et ol .. 1992). Although comrnunily p!Jarrnacists report !ow provision of 
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pharmaceutical care at their pharmacies. they have high behavioral intention to 
provide pharmaceutical care. Study results suggest that the discrepancy between 
behavioral intention and actual bclwvior may be due to (i) low perceived social norm 
by physician (ii) low perceived behavioral control (iii) low self-efficacies vvith 
respect to the means involved in the provision of pharmaceutical care and (iv) low 
effect towards the means involved in the provision of PC. The PJPC model could be 
used to design successful intervention procedures for implementation of PC. 
Farris and Kirking, (1995) used the theory of goal-oriented behaviors and 
showed that attitudes \Vere generally positive and intention to try preventing ffi1:<}. 
correcting drug-therapy problcrns \Vas high. Intention to try \Vas predicted, hovvever 
poorly, by attitude and social norm towards trying after controlling for recency of 
past trying. Another study also by Farris and Kirking, (1998) showed that behaviors 
requiring medium effort were directly prcclictecl by pharmacists' self-efficacy, 
instrumental beliefs and affect towards means. 
An assessment of Canadian community pharmacists' attitude and behavior 
towards pharmaceutical care found that they have moderate to high intention~ 
practice and conceptually see its benefits but believe that there was currently lack of 
appropriate framework in place for the adoption of pharmaceutical care (Faris and 
Schopflocher, 1999). 
1.5.4 Support personnel 
New pharmaceutical care and rapid changes in health care system are 
imposing new demands on hospital and community pharmacy which reslllts in a need 
for increased supportive personnel (manpower). These demands dictate for the 
pharmacist a multifarious role which he can assume only when there are an adequate 
number of personnel within the pharmacy. Studies have indicated that many of the 
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tasks performed in pharmacy could be delegated to supportive personnel under the 
supervision of pharmacists (Skrepnek er a!., 2006). If pharmacist could be freed to a 
greater extent !'rorn performing routine tasks which could be delegated with 
supervision to trained supportive personneL he or she vvould be able to direct more of 
his or her attention to professional tasks only. thereby expanding professional 
pharmacy service in the interest of patient care. This emphasizes the need for 
supportive personnel to assume many of the nonj uclgmental duties traditionally 
associated with delivery of pharmaceutical service (l\SHP, 1983; ASHP, l97l) 
Hospital and community pharmacies must do likewise if it is to make maximum use 
·" 
of pharmacists' unique body of knowledge. and provide an opportunity for 
developing a scope of pharmaceutical care. 
1.6 Practicality of application the pharmaceutical care 
PhanHaceutical care has universal appeal because drug-related tnorbidity and 
mortality knoYvs no boundaries. The consistent and systemic process of providing 
pharmaceutical care holds true without regard to the language spoken. Pharmacists in 
at least 24 countries mG prepared to deliver pharnwceutical care ( Isetts and McKone. 
2003). 
The concept of phannaccutical cme was converted into the practice of 
pharmaceutical care 111 ~~n nction-urietllccl research project callccl fVlinnesota 
Pharmaceutical Cnre Project (Torncchko e/ ul.. Jl)95)_ !\ lt'E:rJt,:mluus Minnesota 
Pharmaceutical Care Project was a 3-year, practice-based initiative conducted 
from June 1992 through November 1995 by Cipolle, Strand, and lVlorley. It 
included 54 pharmacists hom 20 community pharmacy practice sites through the 
state of Minnesota. The intention of the project was to explore the relationships 
between the theory and practice of pharmaceutical care. The word "practice" is 
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important in the tvlirmesota moLlcl: it rnce~ns pharmacists having a practice just like a 
doctor, a dentist, or an optician. 'The denlonsu·at ion project was divided into four 
major phases: (1) the pre-study period involved selection of a representative 
sample site. (2) The pilot-study year to determine if a new practice of 
phannace1ninll cw·e could be cleveloped. (3) The implcrnentation or 
development phase was dedicated to disseminating the practice developed in 
pilot-study phase. ( 4) The evaluation phase was developed to the evaluation of 
the care pharmacists provided to patients through the project The participants 
·" have a prescribed structure (training, equipment, consultation area and 
reimbursement system which rewards them for identifying, preventing or responding 
to drug related problems), adhere to processes (planning. patient monitoring, 
interview, recording) to achieve patient outcomes. ln this project 45,000 
pharmaceutical care encounters have been documented for over 15,000 patients and 
over 19.000 drug therapy problems ickntifiecL prevented and resolved (Mason, 
2001). Part of the result shows Ll1al lhc rnosl fi·cquenl indications for drug therapy in 
patients receiving pharmaceutical care services were sinusitis. bronchitis, otitis 
media, hypertension, and pain. It is interesting that the most frequent problems were 
that patients needed additional clrug tlJcr~lPY (2J<Vo) and <lei verse drug reactions (21 %). 
In common with T'vlinnesoLu tnodeL it f(Jcuses on the burden of medication-related 
problems and ainJs to ensure that medicines are used appropriately, safely, 
effectively and conveniently. 
Another study bas provided evidence lu support the further ckvcloprnent of 
Pharmaceutical c<.:tre concept in New Zealand. In 199't the Plwrmaceutical Society CJf 
New Zealand (PSNZ) adopted quality standards for the practice of comprehensive 
pharmaceutical care (CPC), uf"'lcr the landmark paper published by Hepler and Strand 
t9 
(Hepler and Strand. 1990). 28°/i} of CCHntlll1!1ily pharmacists and 16% of all the 
pharmacists in New Zealand working in cot~junction with the (PSNZ) expressed a 
keen interest in pbannaceutical care application (Isetts and McKone, 2003). The 
number of pharnwcists pruvidin!". phannaceutical care has been cited as a reason that 
the government in that country encoura:;eclto fund the process (Dunlop, 2001). Tbis 
funding was achieved by separating funding frorn a previously profitable dispensing 
remuneration into <l fund i'or co~:.nitivc s·.Tviccs. 
1.7 The levels of pharmaceutical care 
... 
Pharmaceutical care is applicable and achievable by pl:!arn1~tcists in all 
practice settings. The provision of pll<IJTrwccutical cmc is not limited to pharmacists 
in inpatient, outpatient, home care setting or community setting. The care provided 
may differ anwng practice settings and to distinguish in its delivery, theoretical 
aspects in the level of phnnTJaceutical care have been described by Strand ef al., 
(1991). 'fheir view that patient needs must di1lerentiatc the level of c~1re required by 
and provided to a patient and not speci!]c pharmacists activities. Distinguish can be 
expressed in term of the risk associated with patient's phannacotherapy, so they 
identified three categories of risk f~1ctors that can <lll·ect the type and level of 
pharmacotherapeutic risk (1) risk factors associate vvitll the patient's clinical 
characteristics, (2) risk factors associate with the patient's disease, and (3) risk 
factors associate with the patient's pharmacotherapy. The interaction of these three 
types of risk factors ultimately detern~ines the level of risk associated with patient's 
pharmacotherapy and therefore the level of plwnnacculical care required of the 
pharmacist. The pharmacist then transforms these data into relevant information 
through application of knowledge, judgment, and experience. 
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Smith and Benderev, ( 1991) described a "theoretical model'' in which models 
of health-care provision are organized according to level of care, namely, primary, 
secondary, and tertiary levels. Each level of care differs in the magnitude of the four 
factors involved in pharmaceutical care needs by the patient. This patient needs is 
influenced by 1) the patient medical condition, 2) the drug therapy the patient is 
rece1vmg, 3) the degree of action required of the pharmacists, and 4) the inter-
professional relationships betvveen pharmacists and healthcare providers. As 
explicated by Smith and Benderev, primary pharmaceutical care arises when the drug 
therapy needed by the patient is not for a condition that necessitates hospitalizatio~1,. 
the patient's medical conditions is non-acute, chronic, or episodic, the drug therapy 
the patient is receiving is easily observed, the degree of action required of the 
pharmacist is minimal, and the interaction between the pharmacist and the physician 
are infrequent. Primary pharmaceutical care is practiced in outpatient pharmacies in 
hospital, and community pharmacies. Secondary pharmaceutical care starts with the 
initial drug therapy for a mot·e compk~:-; medical condition. The medical condition 
requires hospitalization, the drug therapy the patient is receiving required 
monitoring, patient responsiveness is not as easily observed as in primary care, and 
the pharmacist communicates with physician :n regul<lr intervals. Secondary 
pharmaceutical care is practiced in ~tcutc-carc hospitals, w.1d speciaLized-care 
programs such as oncology and pain control. The most comprehensive clinical 
services are offered for tertiary phamidCt:utical care, whereby patients will require 
intensive monitoring by ph~tnll:ici;;is <Iiid lhis c;m unly tlCcur i11 critiull care service. 
In tertiary care the medical condition required hospitalization, drug therapy must be 
closely monitored by pharmacist as well as frequent inter-professional interactions 
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are required. Tertiary pharmaceutical care 1s practiced 111 hospitrrls that provide 
inpatient critical care services. 
In Malaysian context, the ambulatory settings such as health clinics and 
community may require a primary level pharmaceutical care while the hospitals ma.y 
involve secondary and tertiary levels ofpharmaceutical care (Othman, 2004). 
Most of the reports conccming f'uturc pharmacy practitioners' perceptions, 
undel'standing, and attitudes towards pharmaceutical care arc based on experience in 
developed countries. As the philosophy of pharmaceutical care spr~ads to other parfs 
of the ·world, there is a need to build on professional literature by incorporating 
evidence from the developing countries. 
Malaysia is one of the fronHunners amongst developing countries, where 
clinical practice and pharmaceutical care is gradually dominating the picture of 
professional pharmacy practice. The population of Malaysia is approximately 23.95 
million (in year 2005 population census). Malaysia heavily subsidizes its health care 
service; the Ministry of l-Iealth is the major health care provider in the country. The 
second major provider of health services is the private health sector. There are two 
types of pharmacy practice, government and private. Government pharmacy practice 
takes place rnostly in government hospital and health care faciliiies (Ab Rahman and 
Bahari, 2004). In year 2002, uccorc!ing to Phannacy Board Amlllal l(eport, only 
about 18% of the more than 3000 registL~red pharmacists in the country worked in · 
government sector and 82% \\·'Grk~:.'d in private sector. 
Practitioners are capable ol" implementing clinical phantwcy serv1ces m 
hospital pharmacy settings. 'fhe irnportanl activities in clinically oriented pharmacy 
practice include improvement of the' drug-control process, cleveloprncnt of physical 
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and human resources. clinical pharmacy skills. and the truinin~. of practicing 
pharmacists. A number of Malaysian pharmacists have already developed a unit-dose 
drug distribution system, patient counseling, therapeutic drug monitoring, drug 
information, and total par~ntcr<d nutrition services (Hassan. 1993). A continuing 
effort to advance, expand. nml pron1ok the practice of clinical plwrmacy and patient 
care in Malaysia had been brought about by clinical educators and nevv f~1culty 
members of the School uC Phann~tccutical Sciences (USM), returning £i·om the 
United States with PharmJ) clcgrc(:s (i\b lZalHnan and Bahnri, 200"1: I--Iassan, 1993; 
Hassan. 1990a). 
. .. 
On the other hand, the status of patient-orientated activities beyond dispensing 
of prescriptions revewleci thnt there is no widespread implementation of such 
activities as part of daily practice among the local community pharmacy in Malaysia 
(Sarrif, 1994). In aclclition, pharmacy practice in the community setting varies fi-om 
one pharmacy Lo another. Privak (Community) phannacy practice is mainly 
represented by chain store pharmacies and independent phcmnacies (Wong, 2001). 
Chain-store pharmacies usually ofJ'cr a significant pwportiou of JWn-professional 
services and activitie~; zliong:;ilk tile lr~idtliomtl professional services. Smaller 
independent pharmacies nonnally tocus on professional services (\Vong, 2001). 
Community pharmacies operate under very uni~1vourablc conditions imposed by 
legal and historicnl limits. Many com1nunity pharmacists do llOL have full control 
over the supply ofmcclicincs, since the rneclical doctors' cu1tlrul a large percentage of 
medicines supplied to p<.aients (tvlCPA, 2006a; Wong, 200 l ). Jvlalaysian pharmacists 
need to remedy this Uilbealthy situation in order to be able to contribute more 
meaningfully, as an irllp()Wmt healtllcarc lt'am member or pharmaceutical care 
practice. 
'!" L., .) 
1.9 Barriers to irnplemelding pli~ll'l'ilHettdi<:al care 
All new concepts confront h<tnicrs and challenges, and the concept of 
pharmaceutical care is no exception. 1\s plentiful barriers to providillg clinical 
pharmacy have been identified, these barriers are also presented when considering 
the adoption of pharmaceutical care. Although there are many different environments 
in which pharmaceutical care is provided within the practice settings (e.g., hospital 
and community pharmacy settings), the barriers experienced by the phannacist are 
often shared among these different settings. 
There is universal interest in pharmaceutical care (I;C) practice. Flowever, its 
. ·" 
uptake as daily practice by ditlerent pharmacy settings has been hindered by a 
number of barriers to implementation (Ozolinaa, 2007; Berger and Grimley, 1997; 
Posey, 1997~ Ocledina el a!., 1996). Several pharrJwccuric~·tl literatures tried to 
categorize the baniers to provide phannaceutical care as: system-related, resource-
related, eclucatiorial, legal, professional and aclrninistrati ve barriers, financial, 
information-related, communication-related, structural, I eadersh ip-related, 
pharmacist-related, pharmacy management or plwrnwcy department-related and 
demand-related barriers (AI-Shaqha and Zairi, 2001; May, I 093: Swifr, 1993) and 
there are numerous subcategories of these barriers categories. 
A plethora of barriers to providing clinical phannacy have been vvell-known 
including the gap in plwrnwcy tr<tining. infonnatio11 reslTiclions, cli\Trgences of 
interprotessionaL economic structure. and uneven patient demand (Smith, 1988; 
Baker, 1979). These barrie1·s arc ,-dso present when considering tlie implementation 
of pharmaceutical care (Vutk:tlawrnan el o/., I 9CJ7: I l:tgeclur:J et a!., 1996; Raisch, 
1993; Knapp, 1992 Nelson e/ ul., I 984 ). SpeciJically. altitudinal factors may 
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